The first domestic oral anti-new crown drug approved

The State Food and Drug Administration on the 25th, in accordance with the special drug approval procedures, emergency Approval of Henan True Biotechnology Co., Ltd. Azvudine Tablets with conditions Increase the registration applications for the treatment of new coronavirus pneumonia. The drug is an oral small molecule novel coronavirus pneumonia treatment drug independently developed by my country. On July 20, 2021, the State Food and Drug Administration has conditionally approved the drug in combination with other reverse transcriptase inhibitors to treat adult HIV-1 infected patients with high viral load. This is a conditional approval of an additional indication for the treatment of adult patients with common novel coronavirus pneumonia.. Patients should strictly follow the instructions under the guidance of physicians. The State Food and Drug Administration requires the marketing authorization holder to continue to carry out relevant research work, complete the conditional requirements within a time limit, and submit the follow-up research results in a timely manner. Source: Xinhua ViewpointReporter: Dai Xiaohe

Editor in charge: Zhang Ziqing

Proofreading: Guo Yanhui and Meng Yafei (intern)